Patents/Inventors

James D. Mcininch

Burlington, MAUS20 patents

18 Patents

US125656532026
ATAXIN3 (ATXN3) Rnai Agent Compositions and Methods of Use Thereof
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US125530532026
Transmembrane Serine Protease 2 (TMPRSS2) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US125347312026
Alpha-2a Adrenergic Receptor (ADRA2A) Irna Agent Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US124865122025
Solute Carrier Family Member Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US124801252025
Patatin-like Phospholipase Domain Containing 3 (PNPLA3) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US124735502025
Coagulation Factor V (F5) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US124160062025
Cell Death-inducing Dffa-like Effector B (CIDEB) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US124045082025
Ketohexokinase (KHK) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US123919452025
Coronavirus IRNA Compositions and Methods of Use Thereof
Vir Biotechnology, Inc.
0 cites
US123658962025
Complement Component C3 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US123312972025
Coagulation Factor V (F5) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US122585652025
Complement Component C3 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US119937742024
Huntingtin (HTT) Irna Agent Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US119651662024
Complement Factor B (CFB) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US119590812024
Transthyretin (TTR) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US119268322024
Ketohexokinase (KHK) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US118667102024
Transmembrane Protease, Serine 6 (TMPRSS6) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US116494592023
Superoxide Dismutase 1 (SOD1) Irna Compositions and Methods of Use Thereof for Treating or Preventing Superoxide Dismutase 1-(SOD1-) Associated Neurodegenerative Diseases
Alnylam Pharmaceuticals, Inc.
0 cites